The House select committee investigating the January 6 insurrection will be holding its final public hearing Wednesday at 1 p.m. ET.
House Bill 623
117th Congress(2021-2022)
Gabriella Miller Kids First Research Act 2.0
Active
Active
Passed House on Jul 27, 2022
Overview
Text
Introduced
Jan 28, 2021
Latest Action
Jul 28, 2022
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
623
Congress
117
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Virginia
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
California
Colorado
Florida
Florida
Illinois
Illinois
Illinois
Illinois
Maryland
Massachusetts
Massachusetts
Michigan
Michigan
Minnesota
Nebraska
New Jersey
New York
New York
New York
New York
North Carolina
North Carolina
North Carolina
Oklahoma
Oklahoma
Pennsylvania
Pennsylvania
Pennsylvania
Pennsylvania
Pennsylvania
Pennsylvania
Pennsylvania
Pennsylvania
Pennsylvania
South Carolina
Tennessee
Virginia
Virginia
Virginia
Washington
Washington
West Virginia
House Votes (1)
Senate Votes (0)
Passed
July 27, 2022
Type
Voice Vote
Voice Vote
A vote in which the presiding officer states the question, then asks those in favor and against to say "Yea" or "Nay," respectively, and announces the result according to his or her judgment. The names or numbers of senators voting on each side are not recorded.
Passed/agreed to in House: Pursuant to section 5 of H. Res. 1254, and the motion offered by Mr. Kildee, the following bills passed under suspension of the rules: H.R. 623, as amended; H.R. 3952, as amended; H.R. 3962, as amended; H.R. 4551; H.R. 5313, as amended; H.R. 6933; H.R. 7132, as amended; H.R. 7361; H.R. 7569; H.R. 7624, as amended; H.R. 7733, as amended; and H.R. 7981, as amended.(consideration: CR H7197-7211, H7219-7220, H7223-7237; text: 07/26/2022 CR H7124-7125)
Summary

Gabriella Miller Kids First Research Act 2.0

This bill modifies funding for a pediatric disease research initiative within the National Institutes of Health (NIH).

Currently, this initiative receives funding through FY2023 from the 10-Year Pediatric Research Initiative Fund.

This bill directs certain penalties assessed by the Securities and Exchange Commission against pharmaceutical companies for specified violations to that fund. In making allocations from the fund, the NIH must prioritize pediatric research that does not duplicate existing research activities.

Text (4)
July 28, 2022
July 27, 2022
July 22, 2022
January 28, 2021
Actions (20)
07/28/2022
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
07/27/2022
The title of the measure was amended. Agreed to without objection.
07/27/2022
Pursuant to section 5 of H. Res. 1254, and the motion offered by Mr. Kildee, the following bills passed under suspension of the rules: H.R. 623, as amended; H.R. 3952, as amended; H.R. 3962, as amended; H.R. 4551; H.R. 5313, as amended; H.R. 6933; H.R. 7132, as amended; H.R. 7361; H.R. 7569; H.R. 7624, as amended; H.R. 7733, as amended; and H.R. 7981, as amended. (consideration: CR H7197-7211, H7219-7220, H7223-7237; text: 07/26/2022 CR H7124-7125)
07/27/2022
Passed/agreed to in House: Pursuant to section 5 of H. Res. 1254, and the motion offered by Mr. Kildee, the following bills passed under suspension of the rules: H.R. 623, as amended; H.R. 3952, as amended; H.R. 3962, as amended; H.R. 4551; H.R. 5313, as amended; H.R. 6933; H.R. 7132, as amended; H.R. 7361; H.R. 7569; H.R. 7624, as amended; H.R. 7733, as amended; and H.R. 7981, as amended.(consideration: CR H7197-7211, H7219-7220, H7223-7237; text: 07/26/2022 CR H7124-7125)
07/27/2022
Pursuant to the provisions of H. Res. 1254, proceedings on H.R. 623 are considered vacated.
07/26/2022
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
07/26/2022
DEBATE - The House proceeded with forty minutes of debate on H.R. 623.
07/26/2022
Considered under suspension of the rules. (consideration: CR H7124-7126)
07/26/2022
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
07/22/2022
Placed on the Union Calendar, Calendar No. 337.
07/22/2022
Committee on Financial Services discharged.
07/22/2022
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-431, Part I.
05/18/2022
Ordered to be Reported (Amended) by the Yeas and Nays: 53 - 0.
05/18/2022
Committee Consideration and Mark-up Session Held.
05/11/2022
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
05/11/2022
Subcommittee Consideration and Mark-up Session Held.
02/02/2021
Referred to the Subcommittee on Health.
01/28/2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
01/28/2021
Sponsor introductory remarks on measure. (CR E76-77)
01/28/2021
Introduced in House
Public Record
Record Created
Jan 29, 2021 8:12:09 AM
Record Updated
Sep 7, 2022 1:34:11 PM